Metabolic Syndrome Arrays

Home - Biochip - Metabolic Syndrome Arrays

Metabolic syndrome is a group of cardiovascular risk factors. It is highly prevalent, with approximately 20-25% of adults affected. It is estimated that having metabolic syndrome results in a person being three times more likely to have a stroke or heart attack, and five times more likely to develop diabetes.

Metabolic Syndrome Array I

  • Ferritin
  • Interleukin-6 (IL-6)
  • Insulin
  • Leptin
  • Plasminogen Activator Inhibitor-1 (PAI-1)
  • Resistin
  • Tumour Necrosis Factor α (TNFα)

Metabolic Syndrome Array II

  • Adiponectin
  • C-reactive Protein (CRP)
  • Cystatin C

Key Benefits of Randox Metabolic Syndrome Arrays

  • Multiplex testing from a single sample
  • Suitable for both serum and plasma samples
  • Small sample volume
  • Excellent analytical performance
  • Rapid turnaround time
  • Applicable to fully automated and semi-automated Evidence analysers

Publications | Metabolic Syndrome Array

Publications | Metabolic Syndrome Array II